Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Christina Peters et al.|Bone Marrow Transplantation|2020Cited by 61
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)Domenico Russo, Anna Paola Iori, Mariagrazia Michieli et al.|Bone Marrow Transplantation|2021Cited by 20
The Role of Nutrition in Primary and Secondary Prevention of Cardiovascular Damage in Childhood Cancer SurvivorsFiorentina Guida, Marcello Lanari, Riccardo Masetti et al.|Nutrients|2022Cited by 18
Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP StudyAndré Willasch, Peter Bader, Christina Peters et al.|Blood|2017Cited by 2
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Christina Peters et al.|Bone Marrow Transplantation|2021Cited by 1